Jeffrey Aronin Is Bringing Rare Disease Treatments Into The Mainstream

Jeffrey Aronin has been a developer, a visionary, and entrepreneur of international biotech and healthcare innovative companies for 20 years. He is a brilliant mind in the field of complex science and drug development projects that are designed specifically to address the much needed medical concerns of patients who suffer from rare unaddressed diseases.

 

Mr. Aronin has had many new medicines and technological innovations approved that are used around the world. He presently serves as the Chief Executive Officer and Chairman of Paragon Biosciences. Paragon Biosciences meets the goals and designs of Jeffrey which is to help patients with debilitating diseases live better lives by using his biotech products.

 

Jeffrey and Paragon are helping the patients who would have no medical recourse in their rare disease battle. Jeffrey is achieving what large pharmaceutical companies and large biotech firms could not achieve, which is to get life-saving drugs and treatments approved and into the market quickly.

 

Jeffrey Aronin has years of experience in the pharmaceutical industry as a leading manager for the following biopharmaceutical companies:

 

* Castle Creek Pharmaceuticals

* Harmony Bioscience.

* Ovation Pharmaceuticals later acquired by Lundbeck, Inc.

 

Jeffrey Aronin has a Bachelor of Science degree from Northern Illinois University, a Master of Business Administration from DePaul University. He completed his post-graduate coursework at the Kellogg School of Management of Northwestern University and from the Booth School of Business of the University of Chicago.

 

Mr. Aronin is also the co-chairman and the founder of MATTER which is a new generation biotech firm. He is very involved with financial and medical organizations. Jeffrey is on the board of Discover Financial Services and Castle Creek Pharmaceuticals.

 

His board work continues as the director of the Economic Club of Chicago and the World Business Chicago. Aronin received the Crown Fellowship award from the Aspen Institute. He is a member of the Commercial Club and the Aspen Global Leadership Network.

 

Jeffrey is a regular lecturer at his post-graduate colleges – Kellogg School of Management and Booth School of Business. In 2017, Mr. Aronin was awarded the Weizmann Leadership Award from the Weizmann Institute of Science.

 

As a generous philanthropist, Jeffrey Aronin and his family supports research and patient-centered organizations like the Pediatric Epilepsy Research Foundation, the American Porphyria Foundation, and the Huntington’s Disease Society of America.